{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:51:38Z","timestamp":1781495498817,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.yebeh.2020.107193","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T06:38:15Z","timestamp":1595399895000},"page":"107193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Influence of valproate-induced hyperammonemia on treatment decision in an adult status epilepticus cohort"],"prefix":"10.1016","volume":"111","author":[{"given":"Sarah Folkestad","family":"Habhab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line B\u00e9dos","family":"Ulvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Taub\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Svalheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketil Berg","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Andreas","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107193_bb0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2020.107193_bb0010","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2008.01706_3.x","article-title":"The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus","volume":"49","author":"Shorvon","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107193_bb0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2020.107193_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.9740\/mhc.2018.03.073","article-title":"Valproic acid-induced hyperammonemia: incidence, clinical significance, and treatment management","volume":"8","author":"Baddour","year":"2018","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.yebeh.2020.107193_bb0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eplepsyres.2009.02.012","article-title":"Hyperammonemia following intravenous valproate loading","volume":"85","author":"DeWolfe","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107193_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.yebeh.2007.06.015","article-title":"The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?","volume":"11","author":"Chicharro","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107193_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","article-title":"25 years of advances in the definition, classification and treatment of status epilepticus","volume":"44","author":"Trinka","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107193_bb0040","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy\u2014definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.yebeh.2020.107193_bb0045","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jceh.2014.10.001","article-title":"Definition and nomenclature of hepatic encephalopathy","volume":"5","author":"Dharel","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.yebeh.2020.107193_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.seizure.2019.06.024","article-title":"Predictive performances of STESS and EMSE in a Norwegian adult status epilepticus cohort","volume":"70","author":"Ulvin","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107193_bb0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archneur.1982.00510210061016","article-title":"Asymptomatic hyperammonemia in patients receiving valproic acid","volume":"39","author":"Murphy","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2020.107193_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2019.03.020","article-title":"Intravenous use of valproic acid in status epilepticus is associated with high risk of hyperammonemia","volume":"69","author":"Lind","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107193_bb0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.genhosppsych.2011.12.009","article-title":"Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management","volume":"34","author":"Chopra","year":"2012","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.yebeh.2020.107193_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00655.x","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"114","author":"Segura-Bruna","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2020.107193_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.yebeh.2020.107193_bb0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40263-014-0167-1","article-title":"Efficacy and safety of intravenous valproate for status epilepticus: a systematic review","volume":"28","author":"Trinka","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2020.107193_bb0085","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1185\/03007995.2012.694362","article-title":"Valproate-induced hyperammonemic encephalopathy: a brief review","volume":"28","author":"Lewis","year":"2012","journal-title":"Curr Med Res Opin"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020303723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020303723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:36:10Z","timestamp":1761503770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020303723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":17,"alternative-id":["S1525505020303723"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107193","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of valproate-induced hyperammonemia on treatment decision in an adult status epilepticus cohort","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107193"}}